A 31-year-old woman presented with chest discomfort in the 22nd week of pregnancy. She had been treated with an intravenous infusion of ritodrine hydrochloride (0.25 mg/min) for preterm labor the prior day. On physical examination, the body temperature was 36.3℃, the blood pressure was 117/68 mmHg, the pulse was 96 beats/min, and the respiratory rate was 20 breaths/min. Electrocardiography (ECG) showed ST-T changes resembling ischemia in the inferolateral leads ( Fig. A) with a heart rate of 98 beats/min. An ECG taken the preceding day revealed no ST-T changes (Fig. B) . The ECG in limb lead II showed flattening of the T wave, slight ST depression, and prominent U waves, as in hypokalemia (Fig. C) . QT prolongation and a U wave were prominent in the precordial leads (Fig. A) . Urgent echocardiography to detect cardiac function and ischemic changes showed normal cardiac function without wall motion abnormalities. After discontinuing the ritodrine infusion, the ECG returned to normal the following day ( Fig. D and E) and her chest discomfort resolved. Her serum potassium level, which had been 4.1 mEq/L the previous day, was 3.4 mEq/L, and returned to 4.1 mEq/L after discontinuation of the ritodrine infusion. The serum fasting glucose level was 81 mg/dL, and 80 mg/dL the preceding day. The plasma calcium was 8.8 mg/dL and the magnesium level was 1.9 mg/dL.
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Ritodrine, a beta 2-selective adrenergic drug, is used as a tocolytic drug for management of preterm labor. 1) One of the most common side effects of ritodrine is hypokalemia because of a marked increase in plasma insulin, which results in stimulation of the cellular uptake of potassium.
2)3) Ritodrine-induced hypokalemia shows typical ECG changes resembling hypokalemia typical of other causes. As in this case, typical ECG changes associated with a ritodrine infusion may not be compatible with the absolute serum level of potassium. 
